6533b7d2fe1ef96bd125e213
RESEARCH PRODUCT
Pregabalin as add-on treatment to botulinum toxin in idiopathic hemifacial spasm
Peter P. Urbansubject
MaleBotulinum ToxinsPregabalinPregabalinPhysiology (medical)medicineHumansHemifacial SpasmAdverse effectgamma-Aminobutyric AcidAnti-Dyskinesia Agentsbusiness.industryTherapeutic effectMiddle Agedmedicine.diseaseBotulinum toxinSensory SystemsDiscontinuationDrug CombinationsTreatment OutcomeAdd on treatmentNeurologyAnesthesiaAnticonvulsantsFemaleNeurology (clinical)businessMedical therapymedicine.drugHemifacial spasmdescription
Botulinum toxin (BTX) is the medical therapy of choice in hemifacial spasm (HFS). However, in some patients, its therapeutic effect is insufficient. ### Patient 1. A 64-year-old man with a 10-year history of left-sided HFS was treated with BTX over a period of 6 years with good results. However, in the last 2 years the spasms were never sufficiently relieved by BTX. The patient felt significantly impaired, but declined to undergo neurosurgical intervention. The EDB test showed a decrease in the CMAP amplitude of 60%. Without changing the BTX regime, pregabalin (initially 75 mg/day increased every 5 days by 75 mg to 150 mg twice daily) was added for a 1-month trial period in the absence of adverse effects. The HFS subsided gradually. After discontinuation of the drug at the end of the trial period, the symptoms recurred after <4 weeks. Rechallenge with pregabalin alone at a dosage of 300 mg/day over 4 weeks improved HFS but did …
year | journal | country | edition | language |
---|---|---|---|---|
2007-04-01 | Neurology |